Maabarot Products Ltd. has acquired Laboratoria Natury Sp. z o.o
August 2011 — Maabarot Products Ltd., a company producing and marketing a broad range of nutritional products, has acquired Laboratoria Natury Sp. z o.o, a manufacturer of food supplements, vitamins and minerals in Poland, for US$4.5 million.
Maabarot Products Ltd. and its subsidiaries manufacture and market a broad range of products including baby food, pet food, vitamins, nutritional supplements and organic food. Based in Israel, the company sells its products in Turkey, Cyprus, Italy, Uzbekistan and India. It also exports to Europe, the United States and the Far East.
Polish firm Laboratoria Natury is active in the development, manufacture and marketing of food supplements, vitamins and minerals (VMS). The company specializes in aloe-based preparations, supplying wholesalers, pharmacies and herbal stores as well as some hypermarkets and supermarkets. Laboratoria’s export markets include Hungary, Slovakia, Czech Republic, Lithuania, Croatia, Serbia, Romania and Bulgaria.
Our role in the transaction
Oaklins' teams in Poland and Israel collaborated closely in this transaction. The Israeli team advised Maabarot Products Ltd. on the acquisition process, initiating the transaction and running a structured international search with the full involvement of other Oaklins' teams. After having identified a Polish transaction target, our Polish and Israeli teams jointly concluded the process, originating the contact with the seller, collecting information, advising on valuation, coordinating the due diligence and advising on the negotiations.
Talk to the deal team
Related deals
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreTandem has completed a voluntary public tender offer for the shares of Compagnia dei Caraibi
Tandem S.r.l. has completed a voluntary public tender offer for 25.99% of the shares in Compagnia dei Caraibi S.p.A.
Learn more